trial · primary record
Toripalimab
Immune Checkpoint Inhibitors
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 21 |
| Primary completion | 2028-06-30 |
| Primary endpoint | Pathological Major Response (MPR) |
| Registry ID | NCT06279403 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:48.611Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06279403
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.